IUHSA
CBIO

Itau Unibanco Holding S.A.’s Crescent Biopharma CBIO Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9
Closed -$11K – 926
2019
Q3 		$11K Hold
9
– – ﹤0.01% 280
2019
Q2 		$11K Sell
9
-25
-74% -$29.9K ﹤0.01% 585
2019
Q1 		$31K Hold
34
– – ﹤0.01% 552
2018
Q4 		$31K Hold
34
– – ﹤0.01% 552
2018
Q3 		$50K Sell
34
-1
-3% -$1.51K ﹤0.01% 543
2018
Q2 		$57K Sell
35
-1
-3% -$1.72K 0.01% 611
2018
Q1 		$58K Buy
36
+25
+227% +$52K ﹤0.01% 468
2017
Q4 		$18K Sell
11
-1
-8% -$1.32K ﹤0.01% 509
2017
Q3 		$54K Sell
12
-30
-71% -$35.2K ﹤0.01% 577
2017
Q2 		$47K Buy
42
+37
+740% +$30.6K 0.01% 298
2017
Q1 		$3K Buy
+5
New +$3.07K ﹤0.01% 675

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Itau Unibanco Holding S.A.'s CBIO Position: Q4 2019 in Review

Itau Unibanco Holding S.A. sold out of Crescent Biopharma (CBIO) in Q4 2019, closing a stake of 9 shares — an estimated $11K sold.

Itau Unibanco Holding S.A. first reported a position in CBIO in Q1 2017 and held it in 11 quarters. The position peaked at $58K in Q1 2018. 78 funds tracked by Wall St. Rank hold CBIO as of Q4 2019.

  • Itau Unibanco Holding S.A. reported no remaining Crescent Biopharma position as of Q4 2019 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 9 Crescent Biopharma shares in Q4 2019, an estimated $11K.
  • Itau Unibanco Holding S.A. first reported a position in Crescent Biopharma in Q1 2017 and held it in 11 quarters.
  • Itau Unibanco Holding S.A.'s Crescent Biopharma position peaked at $58K in Q1 2018.
  • 78 funds tracked by Wall St. Rank held Crescent Biopharma as of Q4 2019.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2019, filed 14 Feb 2020.